Double-detargeted oncolytic adenovirus shows replication arrest in liver cells and retains neuroendocrine cell killing ability.

PloS One
J LejaMagnus Essand

Abstract

We have previously developed an oncolytic serotype 5 adenovirus (Ad5) with chromogranin-A (CgA) promoter-controlled E1A expression, Ad[CgA-E1A], with the intention to treat neuroendocrine tumors, including carcinoids. Since carcinoids tend to metastasize to the liver it is important to fully repress viral replication in hepatocytes to avoid adenovirus-related liver toxicity. Herein, we explore miRNA-based regulation of E1A expression as a complementary mechanism to promoter-based transcriptional control. Ad[CgA-E1A-miR122], where E1A expression is further controlled by six tandem repeats of the target sequence for the liver-specific miR122, was constructed and compared to Ad[CgA-E1A]. We observed E1A suppression and replication arrest of the miR122-detargeted adenovirus in normal hepatocytes, while the two viruses killed carcinoid cells to the same degree. Repeated intravenous injections of Ad[CgA-E1A] induced liver toxicity in mice while Ad[CgA-E1A-miR122] injections did not. Furthermore, a miR122-detargeted adenovirus with the wild-type E1A promoter showed reduced replication in hepatic cells compared to wild-type Ad5 but not to the same extent as the miR122-detargeted adenovirus with the neuroendocrine-selective CgA promoter...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Oct 22, 2003·Cell·Dianne S SchwarzPhillip D Zamore
Jun 24, 2004·Nature Reviews. Genetics·Lin He, Gregory J Hannon
Aug 6, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Wing-Shing ChengMagnus Essand
Sep 17, 2004·Nature·Victor Ambros
Dec 6, 2005·Journal of Molecular Endocrinology·M EssandV Giandomenico
Apr 18, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Justyna LejaMagnus Essand
Jun 23, 2007·Current Gene Therapy·Samuel K Campos, Michael A Barry
Jul 4, 2007·Nature Reviews. Genetics·Reinhard WaehlerDavid T Curiel
Aug 25, 2007·Cellular and Molecular Life Sciences : CMLS·K B HelleB Tota
Feb 23, 2008·Journal of Hepatology·Muriel GirardAlexandra Henrion-Caude
Jul 31, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Takayuki SuzukiHiroyuki Mizuguchi
Oct 28, 2008·Nature Medicine·Elizabeth J KellyStephen J Russell

❮ Previous
Next ❯

Citations

May 16, 2014·Endocrine Journal·Padmanaban S SureshRie Tsutsumi
Apr 29, 2011·Gene Therapy·J A Broderick, P D Zamore
Jul 3, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mohanraj RamachandranFredrik Eriksson
Sep 27, 2013·PloS One·Elisa CallegariSilvia Sabbioni
Mar 2, 2012·Neuroendocrinology·Magnus Essand
Apr 16, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Rubén Hernández-Alcoceba
Feb 12, 2011·Cancer Metastasis Reviews·Kjell Oberg, Daniel Castellano
Sep 3, 2013·Expert Opinion on Therapeutic Targets·Marije J VeenstraLeo J Hofland
Jul 14, 2012·Expert Opinion on Biological Therapy·Donavon C Hiss, Burtram C Fielding
Oct 2, 2012·Tissue Antigens·B Gentner, L Naldini
May 27, 2016·World Journal of Experimental Medicine·Anja Geisler, Henry Fechner
Jun 8, 2017·Journal of Medical Ethics·Alexander Masters, Dominic Nutt
May 7, 2020·Cancers·Jian GaoAnja Ehrhardt
Jun 13, 2020·Cancers·Praveensingh B HajeriMasato Yamamoto
Dec 14, 2016·Antioxidants & Redox Signaling·Di ShaoMarkus M Bachschmid
Sep 18, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mohanraj RamachandranMagnus Essand
Feb 25, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kumiko SugioHiroyuki Mizuguchi

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
biopsies

Software Mentioned

GraphPad

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
J LejaMagnus Essand
International Journal of Obesity : Journal of the International Association for the Study of Obesity
P-W SoJ D Bell
Archives of Otolaryngology--head & Neck Surgery
Takahiro NakagawaKen-ichi Nibu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Daniel T ReinDavid T Curiel
© 2021 Meta ULC. All rights reserved